Glucuronidation of curcuminoids by human microsomal and recombinant UDP-glucuronosyltransferases

Molecular Nutrition and Food Research

Volumn 51, Issue 8, 2007, Pages 932-938

  Hoehle, Simone I ^a   Pfeiffer, Erika ^a   Metzler, Manfred ^a  

^a UNIVERSITY OF KARLSRUHE   (Germany)

Author keywords

Curcumin; Glucuronidation; Microsomes; UGTs

Indexed keywords

CURCUMIN; GLUCURONIDE; GLUCURONOSYLTRANSFERASE; ISOENZYME; RECOMBINANT PROTEIN;

ARTICLE; FEMALE; HUMAN; INTESTINE; LIVER MICROSOME; MALE; METABOLISM; MICROSOME; ULTRASTRUCTURE;

CURCUMIN; FEMALE; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; HUMANS; INTESTINES; ISOENZYMES; MALE; MICROSOMES; MICROSOMES, LIVER; RECOMBINANT PROTEINS;

EID: 34548065533     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200600283     Document Type: Article

References (35)

1. Govindarajan, V. S., Turmeric-Chemistry, technology, and quality, Crit. Rev. Food Sci. Nutr. 1980, 12, 199-301.
2. Joe, B., Vijaykumar, M., Lokesh, B. R., Biological properties of curcumin-cellular and molecular mechanisms of action, Crit. Rev. Food Sci. Nutr. 2004, 44, 97-111.
3. Aggarwal, B. B., Kumar, A., Bharti, A. C., Anticancer potential of curcumin: Preclinical and clinical studies, Anticancer Res. 2003, 23, 636-398.
4. Leu, T. H., Maa, M. C., The molecular mechanisms for the antitumorigenic effect of curcumin, Curr. Med. Chem. Anti-Cancer Agents 2002, 2, 357-370.
5. Rao, C. V., Rivenson, A., Simi, B., Reddy, B. S., Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound, Cancer Res. 1995, 55, 259-266.
6. Garcea, G., Berry, D. P., Jones, D. J., Singh, R. et al., Consumption of the putative chemopreventive agent curcumin by cancer patients: Assessment of curcumin levels in the colorectum and their pharmacodynamic consequences, Cancer Epidemiol. Biomarkers Prev. 2005, 14, 120-125.
7. Garcea, G., Jones, D. J., Singh, R., Dennison, A. R. et al., Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration, Br. J. Cancer 2004, 90, 1011-1015.
8. Sharma, R. A., Gescher, A. J., Steward, W. P., Curcumin: The story so far, Eur. J. Cancer 2005, 41, 1955-1968.
9. 2 production, Cancer Res. 2001, 61, 1058-1064.
10. Ireson, C. R., Jones, D. J., Orr, S., Coughtrie, M. W et al., Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine, Cancer Epidemiol. Biomarkers Prev. 2002, 11, 105-111.
11. Hoehle, S. I., Pfeiffer, E., Solyom, A. M., Metzler, M., Metabolism of curcuminoids in tissue slices and subcellular fractions from rat liver, J. Agrie. Food Chem. 2006, 54, 756-764.
12. Asai, A., Miyazawa, T., Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma, Life Sci. 2000, 67, 2785-2793.
13. Pan, M. H., Huang, T. M., Lin, J. K., Biotransformation of curcumin through reduction and glucuronidation in mice, Drug Metab. Dispos. 1999, 27, 486-494.
14. Pfeiffer, E., Hoehle, S. I., Walch, S. G., Riess, A. et al., Curcuminoids form reactive glucuronides in vitro, J. Agric. Food Chem. 2007, 55, 538-544.
15. King, C. D., Rios, G. R., Green, M. D., Tephly, T. R., UDPglucuronosyltransferases, Curr. Drug Metab. 2000, 1, 143-161.
16. Radominska-Pandya, A., Czernik, P. J., Little, J. M., Battaglia, E. et al., Structural and functional studies of UDP-glucuronosyltransferases, DrugMetab. Rev. 1999, 31, 817-899.
17. Mackenzie, P. I., Walter Bock, K., Burchell, B., Guillemette, C. et al., Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily, Pharmacogenet. Genomics 2005, 15, 677-685.
18. Bosma, P. J., Seppen, J., Goldhoorn, B., Bakker, C. et al., Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man, J. Biol. Chem. 1994, 269, 17960-17964.
19. Turgeon, D., Carrier, J. S., Levesque, E., Hum, D. W et al., Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members, Endocrinology 2001, 142, 778-787.
20. Senafi, S. B., Clarke, D. J., Burchell, B., Investigation of the substrate specificity of a cloned expressed human bilirubin UDP- glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation, Biochem. J. 1994, 303, 233-240.
21. Tukey, R. H., Strassburg, C. P., Human UDP-glucuronosyltransferases: Metabolism, expression, and disease, Annu. Rev. Pharmacol. Toxicol. 2000, 40, 581-616.
22. Strassburg, C. P., Nguyen, N., Manns, M. P., Tukey, R. H., UDP-glucuronosyltransferase activity in human liver and colon, Gastroenterology 1999, 116, 149-160.
23. Pabon, H. J. J., A synthesis of curcumin and related compounds, Recl. Trav. Chim. Pays-Bas 1964, 83, 379-386.
24. Lake, B. G., in: Snell, K., Mulloch, B. (Ed.) Biochemical Toxicology, A Practical Approach, IRL Press, Oxford 1987, pp. 183-215.
25. Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 1976, 72, 248-254.
26. Wang, Y. J., Pan, M. H., Cheng, A. L., Lin, L. I. et al., Stability of curcumin in buffer solutions and characterization of its degradation products, J. Pharm. Biomed. Anal. 1997, 15, 1867-1876.
27. Fisher, M. B., Vandenbranden, M., Findlay, K., Burchell, B. et al., Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: Relationship between UGT1A1 promoter genotype and variability in a liver bank, Pharmacogenetics 2000, 10, 727-739.
28. Basu, N. K., Kole, L., Kubota, S., Owens, I. S., Human UDP-glucuronosyltransferases show atypical metabolism of mycophenolic acid and inhibition by curcumin, Drug Metab. Dispos. 2004, 32, 768-773.
29. Sharma, R. A., Euden, S. A., Platton, S. L., Cooke, D. N. et al, Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance, Clin. Cancer Res. 2004, 10, 6847-6854.
30. Ethell, B. T., Beaumont, K., Rance, D. J., Burchell, B., Use of cloned and expressed human UDP-glucuronosyltransferases for the assessment of human drug conjugation and identification of potential drug interactions, Drug Metab. Dispos. 2001, 29, 48-53.
31. Lepine, J., Bernard, O., Plante, M., Tetu, B. et al., Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium, J. Clin. Endocrinol. Metab. 2004, 89, 5222-5232.
32. Ebner, T., Burchell, B., Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family, Drug Metab. Dispos. 1993, 21, 50-55.
33. Cheng, Z., Radominska-Pandya, A., Tephly, T. R., Studies on the substrate specificity of human intestinal UDP-glucuronosyltransferases 1A8 and 1A10, Drug Metab. Dispos. 1999, 27, 1165-1170.
34. Sutherland, L., Ebner, T., Burchell, B., The expression of UDP-glucuronosyltransferases of the UGT1 family in human liver and kidney and in response to drugs, Biochem. Pharmacol. 1993, 45, 295-301.
35. McGurk, K. A., Brierley, C. H., Burchell, B., Drug glucuronidation by human renal UDP-glucuronosyltransferases, Biochem. Pharmacol. 1998, 55, 1005-1012.